Utility of Point-of-Care Fluorescence for Detection of Elevated Bacterial Burden in an Outpatient Wound Care Setting
Charles Andersen, MD, FACS, MAPWCA
Chief, Vascular/ Endovascular/ Limb Preservation, Surgery Service (Emeritus),
Chief Wound Care Service MAMC Medical Director Wound Care Clinic, Madigan
Army Medical Center, Tacoma, WA
Duration: 15 minutes
Talk Overview: Elevated bacterial burden hinders wound healing. The MolecuLight i:X handheld point-of-care fluorescence imaging system enhances detection of elevated bacterial loads in wounds, when used in combination with clinical assessment. This session will provide an overview of how this technology works, how it can be easily incorporated into your clinical workflow, and how increased information on bacterial burden informs clinical decision making.
Adopting Fluorescence Imaging for Detection of Elevated Bacterial Burden as a Standard of Care in our Long-Term Care Facilities
Martha Kelso, RN, LNC, HBOT
Chief Executive Officer, Wound Care Plus, LLC
Blue Springs, MO
Duration: 15 minutes
Talk Overview: Long-term care (LTC) facilities have a disproportionately high rate of wounds and related infections compared to the general population. Many of these wounds, if left undetected, require hospitalization and can lead to more serious complications such as sepsis. Early identification of bacterial burden in wounds is essential to preventing these detrimental outcomes. WoundCare Plus CEO Martha Kelso will describe how the information provided by fluorescence imaging, when used in combination with clinical assessment, improves detection of wounds with elevated bacterial burden. She will also describe how this additional information has transformed how her team of wound care consultants manages wounds in the LTC setting.
Clinical Perspective: My Experience Using & Billing for the MolecuLight Wound Imaging Procedure
Eric Lullove, DPM, CWSP, FAPWH(c)
Chief Medical Officer, West Boca Center for Wound Healing
Coconut Creek, FL
Duration: 15 minutes
Talk Overview: Adding MolecuLight i:X fluorescence imaging procedure to clinical assessment improves identification of wounds with elevated bacterial burden. In this session, Dr. Eric Lullove, Chief Medical Officer, West Boca Center for Wound Healing describes how fluorescence imaging informs his podiatric practice and share insights in billing for this procedure.
Legal and Medical Implications: Fluorescence Imaging for Detection of Elevated Bacterial Burden
Martha Kelso, RN, LNC, HBOT
Chief Executive Officer, Wound Care Plus, LLC
Blue Springs, MO
Duration: 15 minutes
Talk Overview: When new technology is introduced to the marketplace, the landscape can often change with evidence and clinician adoption of this technology. Being able to anticipate the ripple effect from a medical and legal implication can be invaluable when planning growth and strategy for medical organizations. Join Martha R Kelso as she discusses potential future implications and how her company, Wound Care Plus assimilated fluorescence imaging (MolecuLight i:X) into their wound care practice to reduce litigious events, while creating a standard of care in the long-term care setting.
